Skip to main content

Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1633))

Abstract

Precise quantitation of allelic burden for a pathogenic mutation has diverse clinical and research applications but can be difficult to achieve with conventional qPCR-based techniques, especially at lower mutant allele frequencies. Digital PCR overcomes many of the limitations of qPCR and can be highly quantitative even for single-nucleotide variants, with distinct advantages over next-generation sequencing approaches. Here we describe a method combining the principles of TaqMan®-chemistry SNP genotyping with microfluidic digital PCR to generate a highly sensitive, quantitative allele-specific digital PCR assay for the six most common IDH1 and IDH2 mutations encountered in myeloid malignancy. The concept and approach could easily be applied to other suitable SNVs.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Losman JA, Kaelin WG (2013) What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev 27:836–852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Thiede C, Steudel C, Mohr B et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326–4335

    Article  CAS  PubMed  Google Scholar 

  3. Grimwade D, Freeman SD (2014) Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”? Blood 124:3345–3355

    Article  CAS  PubMed  Google Scholar 

  4. Schnittger S, Kern W, Tschulik C et al (2009) Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. Blood 114:2220–2231

    Article  CAS  PubMed  Google Scholar 

  5. Roma C, Esposito C, Rachiglio AM et al (2013) Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology. Biomed Res Int 2013:385087

    Article  PubMed  PubMed Central  Google Scholar 

  6. Matsuda K, Sugano M, Honda T (2012) PCR for monitoring of minimal residual disease in hematologic malignancy. Clin Chim Acta 413:74–80

    Article  CAS  PubMed  Google Scholar 

  7. Huggett JF, Foy CA, Benes V et al (2013) The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin Chem 59:892–902

    Article  CAS  PubMed  Google Scholar 

  8. Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci U S A 96:9236–9241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dube S, Qin J, Ramakrishnan R (2008) Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One 3:e2876

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bhat S, Herrmann J, Armishaw P et al (2009) Single molecule detection in nanofluidic digital array enables accurate measurement of DNA copy number. Anal Bioanal Chem 394:457–467

    Article  CAS  PubMed  Google Scholar 

  11. Huggett JF, Cowen S, Foy CA (2015) Considerations for digital PCR as an accurate molecular diagnostic tool. Clin Chem 61:79–88

    Article  CAS  PubMed  Google Scholar 

  12. Wiseman DH, Struys EA, Wilks DP et al (2015) Direct comparison of quantitative digital PCR and 2-hydroxyglutarate enantiomeric ratio for IDH mutant allele frequency assessment in myeloid malignancy. Leukemia 29:2421–2423

    Article  CAS  PubMed  Google Scholar 

  13. Shen GQ, Abdullah KG, Wang QK (2009) The TaqMan method for SNP genotyping. Methods Mol Biol 578:293–306

    Article  CAS  PubMed  Google Scholar 

  14. Schleinitz D, Distefano JK, Kovacs P (2011) Targeted SNP genotyping using the TaqMan® assay. Methods Mol Biol 700:77–87

    Article  CAS  PubMed  Google Scholar 

  15. Whale AS, Cowen S, Foy CA et al (2013) Methods for applying accurate digital PCR analysis on low copy DNA samples. PLoS One 8:e58177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Wiseman, D.H., Somervaille, T.C.P. (2017). Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia. In: Fortina, P., Londin, E., Park, J., Kricka, L. (eds) Acute Myeloid Leukemia. Methods in Molecular Biology, vol 1633. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7142-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7142-8_15

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7140-4

  • Online ISBN: 978-1-4939-7142-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics